mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.9 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
-0.0077 |
0.9 |